India's Health Ministry Cracks Down on Stem Cells, Pharmacies, and Patient Safety

India's Health Ministry is tightening oversight across multiple fronts this week, targeting unproven stem cell therapies, prescription drug sales, and hospital quality standards in a coordinated push for stricter healthcare regulation. The Ministry issued an advisory on September 16 to all states and Union Territories, following a January 30, 2026 Supreme Court judgment, that explicitly bars routine stem cell therapy for Autism Spectrum Disorder (ASD) — restricting such use to...